Harvard Bioscience (HBIO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.13 +1.49%
Financial Fact:
Other income (expense), net: -67K
Today's EPS Names:
HYFT, ESBS, PFBK, More
Financial Fact:
Other income (expense), net: -67K
Today's EPS Names:
HYFT, ESBS, PFBK, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $21.77 million versus the consensus estimate of $20 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
- Jefferies Downgrades Henry Boot Plc (BOOT:LN) to Hold
- Sonoco (SON) Tops Q2 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
